Steven Rosinski in Bullhead City, Arizona

Home Arizona Bullhead City

Steven Rosinski has Hematology/oncology as his primary medical specialty. Their primary office is: 2500 Canyon Rd in Bullhead City, Arizona.

They're a part of the: Phoenix Cancer And Blood Disorder Treatment Institute Pllc medical group which has around 4 members. You can call their office at 928-224-0064 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Colorado School Of Medicine, Denver and graduated in 2005 (around 19 years of experience). They are listed as doing telehealth appointments.

Steven L Rosinski Office Phone and Directions

Steven Rosinski
Phoenix Cancer And Blood Disorder Treatment Institute Pllc
2500 Canyon Rd
Bullhead City, Arizona 86442
928-224-0064

Patient Ratings
Please rate your experience with Steven Rosinski below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 928-224-0064

Enter a starting address:

Healthcare Info for Steven Rosinski

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: University Of Colorado School Of Medicine, Denver
Graduation Year: 2005
The Primary Medical Specialty for Steven Rosinski is listed as: Hematology/oncology
Approximate Years of Experience: 19
PAC (PECOS ID)#: 8123295375
NPI #: 1073621819
NPI Created On: 08/29/2006
NPI Last Updated Listed as: 06/09/2020
Primary Taxonomy Code: 207R00000X
License Number:
MD60001467
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Montana Health Cooperative
PacificSource Health Plans
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Bone marrow biopsy and aspiration
Hydration infusion into a vein 31 minutes to 1 hour
Hydration infusion into a vein
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
Infusion of different chemotherapy drug or substance into a vein
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
Irrigation of implanted venous access drug delivery device
New patient office or other outpatient visit, typically 30 minutes
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 5 minutes
Established patient office or other outpatient visit, typically 15 minutes

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788999205

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788999207

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788999209

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788999211

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788999213

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781014289

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781014291

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781014293

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795885981

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818704115

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: VERZENIO

Associated Drug #2: 0002-6216-54

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: RETEVMO

Name Of Drug #3: 0002-2980-60

Hematology/oncology Professionals in Bullhead City

1.
Valerie Israel DO

2755 Silver Creek Rd
Bullhead-city, AZ
Gordon Grado Md Inc

2.
Muhammad Ghani MD

2020 Silver Creek Rd
Bullhead-city, AZ
Allison Curtis Kingsley Meoz Michael And Sanchez Pc

Providers in Phoenix Cancer And Blood Disorder Treatment Institute Pllc

1.Kellie Rosinski

2500 Canyon Rd
Bullhead City Az 86442-8493
Phoenix Cancer And Blood Disorder Treatment Institute Pllc
Internal Medicine

2.Steven Rosinski

2500 Canyon Rd
Bullhead City Az 86442-8493
Phoenix Cancer And Blood Disorder Treatment Institute Pllc
Hematology/oncology

3.Clara Sewell

2500 Canyon Rd
Bullhead City Az 86442-8493
Phoenix Cancer And Blood Disorder Treatment Institute Pllc
Physician Assistant

4.Norman Willis Md

967 Hancock Rd
Bullhead City Az 86442-5169
Phoenix Cancer And Blood Disorder Treatment Institute Pllc
Radiation Oncology

View all 4 members of Phoenix Cancer And Blood Disorder Treatment Institute Pllc medical group